Nearly 1.5 million people die from tuberculosis every year, even though most cases can be cured with routine antibiotic treatments. One country’s fight to get the ancient scourge under control has an unlikely hero: a simple diagnostic test.
The chemical-sniffing setup will send data to the Web so doctors and patients can get a better sense of what causes attacks.
In an experimental trial, surgeons have implanted deep-brain stimulators into U.S. and Canadian Alzheimer’s patients.
A compound derived from a toxin from scorpion venom could help neurosurgeons differentiate between healthy and cancerous brain tissue.
By mimicking genetic variation in people with naturally low levels of cholesterol, drug developers are hoping to create a new drug.
Regulatory approval of a gene therapy treatment in Europe could spark broader patient access to the technology.
A coming generation of devices promise clear, high-quality vision for the blind.
Scanadu hopes its tricorder-like device and a smartphone will help people track their health and diagnose problems.
A new device will let scientists create complex patterns of activity within the brain using optogenetics.
Researchers are using genomics to breed a better Thanksgiving bird.